Study to Predict the Need for Humidification Use and Comparison of the Effect of ThermoSmart™ and no Humidification on Adherence

NCT ID: NCT01517750

Last Updated: 2015-06-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-01-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite the effectiveness of continuous positive airway pressure (CPAP) in abolishing upper airway obstruction, acceptance of and adherence with therapy has been sub-optimal. One of the only technological advancements shown to increase adherence is heated humidification, now considered part of conventional CPAP therapy in some countries. ThermoSmart™ is a unique technology developed by Fisher \& Paykel Healthcare which utilises a heated breathing tube to deliver optimal humidity in all environments. ThermoSmart has been shown to be superior to conventional humidification in reducing side effects, condensation and titrated pressure as well as increasing total sleep time. However, improved humidity delivery has not lead to significantly increased adherence in unselected obstructive sleep apnea (OSA) patients.

A total of 80 patients diagnosed with OSA but naive to CPAP use will be randomized into a single blind, randomized, parallel-arm trial to determine whether the the use of heated humidification will impact therapy adherence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Apnea, Obstructive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

APAP with humidification

ICON Auto CPAP™ with Thermosmart heated tube

Group Type EXPERIMENTAL

ICON Auto CPAP™ with Thermosmart heated tube

Intervention Type DEVICE

ICON Auto CPAP™ with heated humidification and the use of a heated tube

APAP without humidification

ICON Auto CPAP™ without Thermosmart heated tube

Group Type ACTIVE_COMPARATOR

ICON Auto CPAP™ without Thermosmart heated tube

Intervention Type DEVICE

ICON Auto CPAP™ without heated humidification or the use of a heated tube.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ICON Auto CPAP™ with Thermosmart heated tube

ICON Auto CPAP™ with heated humidification and the use of a heated tube

Intervention Type DEVICE

ICON Auto CPAP™ without Thermosmart heated tube

ICON Auto CPAP™ without heated humidification or the use of a heated tube.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with OSA
* Naïve to CPAP therapy, i.e have not been prescribed, or used CPAP in the last 5 years
* Prescribed a nasal mask (as patients will be prescribed their mask following recruitment into the study, any participants who are prescribed a full face mask will be withdrawn)

Exclusion Criteria

* Severe heart disease
* Co-existing lung disease
* Co-existing sleep disorders
* Pregnant
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helios Klinik Ambrock

OTHER

Sponsor Role collaborator

Fisher and Paykel Healthcare

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Georg Nilius, Dr.

Role: PRINCIPAL_INVESTIGATOR

Helios Klinik Ambrock

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Helios - Klinik Ambrock

Hagen, Weg, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

References

Explore related publications, articles, or registry entries linked to this study.

Nilius G, Franke KJ, Domanski U, Schroeder M, Ruhle KH. Effect of APAP and heated humidification with a heated breathing tube on adherence, quality of life, and nasopharyngeal complaints. Sleep Breath. 2016 Mar;20(1):43-9. doi: 10.1007/s11325-015-1182-2. Epub 2015 May 10.

Reference Type DERIVED
PMID: 25957615 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FPH-OSA-TS-2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

STIMIT Activator 1 IDE Study
NCT05883163 RECRUITING NA
Post-Market BTVA Registry
NCT03318406 RECRUITING
CPAP in Liver Transplant
NCT00510770 UNKNOWN PHASE4
Carbon Dioxide Investigation
NCT06715410 COMPLETED NA